Aging in Rhesus Monkeys: Relevance to Human Health Interventions
George S. Roth(National Institute on Aging), Donald K. Ingram(Pennington Biomedical Research Center), Mary Ann Ottinger(University of Houston), Mark A. Lane(Birmingham and Midland Eye Centre), Mark E. Chachich(University of South Carolina), Julie A. Mattison(National Institute on Aging)
Cited by 363
Related Papers
Adverse Outcome Pathway (AOP) Development I: Strategies and Principles
|Toxicological Sciences|2014|725
Interventions to Slow Aging in Humans: Are We Ready?
|Aging Cell|2015|598
The AGE Inhibitor Pyridoxamine Inhibits Development of Retinopathy in Experimental Diabetes
|Diabetes|2002|356
GLP-1 Receptor Stimulation Reduces Amyloid-β Peptide Accumulation and Cytotoxicity in Cellular and Animal Models of Alzheimer's Disease
|Journal of Alzheimer s Disease|2010|325
A cross-link breaker has sustained effects on arterial and ventricular properties in older rhesus monkeys
|Proceedings of the National Academy of Sciences|2001|262